Zaya1-8B is a huge shift in LLMs, and the results are impressive.
What's CODE SWITCH? It's the fearless conversations about race that you've been waiting for. Hosted by journalists of color, our podcast tackles the subject of race with empathy and humor. We explore ...
Vincent et al. report the effect of MEK inhibitor trametinib in two children with syndromic KRAS-related multiple non-ossifying fibromas (NOFs). This treatment in vitro reduces KRAS pathway ...